Ole Andreas Halvorsen - Viking Global Investors 13F Activity & Position Changes (Q2 2026)
According to the SEC 13F filed on Aug 14, 2026, the Viking Global Investors portfolio showed several notable changes in holdings as of quarter-end Jun 30, 2026. The activity included new positions, additions to existing holdings, reductions, and complete exits, providing a clear view of how the portfolio evolved during the quarter.
During Q2 2026, the filing reported:
New Buys - Altimmune, Inc., Aptiv, AvalonBay Communities, Inc., BCE, Inc., Bruker Corporation, and 20 more
Increases - Amazon.com, Inc., Aon Plc, Air Products and Chemicals, Inc, Boeing Company (The), BioMarin Pharmaceutical Inc., and 13 more
Reductions - Amer Sports, ATI Inc., BridgeBio Pharma, Inc., Chubb Limited, Capital One Financial Corporati, and 19 more
Complete Exits - Apple Inc., American International Group, I, Arthur J. Gallagher & Co., APi Group Corporation, Cboe Global Markets, Inc., and 14 more
These updates highlight how the portfolio adjusted across different sectors and market conditions, offering insights into allocation shifts and investment trends.
| Date | Symbol | Type | Change Qty |
|---|---|---|---|
|
Q2 2026
|
AAPL
Apple Inc.
|
Sell - Position Exit |
-3,593,057
|
|
Q2 2026
|
AIG
American International Group, I
|
Sell - Position Exit |
-4,221,223
|
|
Q2 2026
|
AJG
Arthur J. Gallagher & Co.
|
Sell - Position Exit |
-727,441
|
|
Q2 2026
|
ALT
Altimmune, Inc.
|
Buy - Position Entry |
+6,700,000
|
|
Q2 2026
|
AMZN
Amazon.com, Inc.
|
Buy |
+2,505,434
|
|
Q2 2026
|
AON
Aon Plc
|
Buy |
+64,155
|
|
Q2 2026
|
APD
Air Products and Chemicals, Inc
|
Buy |
+636,256
|
|
Q2 2026
|
APG
APi Group Corporation
|
Sell - Position Exit |
-5,837,000
|
|
Q2 2026
|
APTV
Aptiv
|
Buy - Position Entry |
+4,552,887
|
|
Q2 2026
|
AS
Amer Sports
|
Sell |
-1,316,125
|
|
Q2 2026
|
ATI
ATI Inc.
|
Sell |
-2,178,963
|
|
Q2 2026
|
AVB
AvalonBay Communities, Inc.
|
Buy - Position Entry |
+1,339,782
|
|
Q2 2026
|
BA
Boeing Company (The)
|
Buy |
+78,784
|
|
Q2 2026
|
BBIO
BridgeBio Pharma, Inc.
|
Sell |
-1,893,215
|
|
Q2 2026
|
BCE
BCE, Inc.
|
Buy - Position Entry |
+8,383,278
|
|
Q2 2026
|
BMRN
BioMarin Pharmaceutical Inc.
|
Buy |
+554,486
|
|
Q2 2026
|
BRKR
Bruker Corporation
|
Buy - Position Entry |
+893,491
|
|
Q2 2026
|
BTSG
BrightSpring Health Services, I
|
Buy - Position Entry |
+1,618,237
|
|
Q2 2026
|
CB
Chubb Limited
|
Sell |
-917,699
|
|
Q2 2026
|
CBOE
Cboe Global Markets, Inc.
|
Sell - Position Exit |
-688,417
|
|
Q2 2026
|
CCL
Carnival Corporation
|
Sell - Position Exit |
-13,721,348
|
|
Q2 2026
|
CLS
Celestica, Inc.
|
Sell - Position Exit |
-1,654,989
|
|
Q2 2026
|
CME
CME Group Inc.
|
Buy - Position Entry |
+152,980
|
|
Q2 2026
|
COF
Capital One Financial Corporati
|
Sell |
-1,224,559
|
|
Q2 2026
|
CPT
Camden Property Trust
|
Sell |
-202,091
|
|
Q2 2026
|
CRBG
Corebridge Financial Inc.
|
Buy - Position Entry |
+2,679,371
|
|
Q2 2026
|
CSX
CSX Corporation
|
Sell - Position Exit |
-18,678,052
|
|
Q2 2026
|
CVNA
Carvana Co.
|
Buy |
+9,542,276
|
|
Q2 2026
|
CVS
CVS Health Corporation
|
Buy - Position Entry |
+3,663,361
|
|
Q2 2026
|
DB
Deutsche Bank
|
Buy - Position Entry |
+2,510,554
|
Page 1 of 6